Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous study content. This indicates the study record is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-23T00:09:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an underlying update to the page version behind the study details.
    Difference
    0.1%
    Check dated 2026-09-16T00:23:00.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page footer revision indicator was updated from v3.6.5 to v3.6.6. This reflects a minor page update without changing core content or study details.
    Difference
    0.1%
    Check dated 2026-09-01T20:01:30.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.4 to v3.6.5, indicating a minor update to the site's revision history. This change appears to be administrative and does not modify the visible content of the study page.
    Difference
    0.1%
    Check dated 2026-08-11T19:35:48.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, signaling a small update to the page's implementation.
    Difference
    0.1%
    Check dated 2026-07-21T12:44:44.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The page shows a revision update from Revision: v3.6.0 to Revision: v3.6.3, indicating a software update to the study details page.
    Difference
    0.1%
    Check dated 2026-06-30T00:56:28.000Z thumbnail image

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.